ClinicalTrials.govcontrolled
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or
ClinicalTrials.gov study NCT00946647. IPD Sharing: YES. Countries: 14. Publications: 1.
ShareScore
40/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 16
- Harmonization
- 12
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 8